RJMty19 (CD19-CAR-DNT cells)

BIOLOGICAL2 trials

Sponsors

Guangdong Ruishun Biotech Co., Ltd

Conditions

B-cell Non-Hodgkin's LymphomaSystemic Lupus Erythematosus

Phase 1

A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL

Not yet recruitingNCT06314828

Guangdong Ruishun Biotech Co., LtdB-cell Non-Hodgkin's Lymphoma

Start: 2024-05-20End: 2027-05-20Target: 30Updated: 2024-03-18

A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)

Not yet recruitingNCT06340490

Guangdong Ruishun Biotech Co., LtdSystemic Lupus Erythematosus

Start: 2024-05-15End: 2027-12-31Target: 24Updated: 2024-04-01